VAM
TGTX icon

Visium Asset Management’s TG Therapeutics TGTX Stock Holding History

Visium Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-525,000
Closed -$4.47M – 495
2016
Q1 		$4.47M Buy
+525,000
New +$4.59M 0.08% 278
2015
Q4 		– Sell
-500,000
Closed -$5.04M – 860
2015
Q3 		$5.04M Sell
500,000
-30,000
-6% -$447K 0.07% 296
2015
Q2 		$8.79M Sell
530,000
-771,500
-59% -$12.2M 0.13% 176
2015
Q1 		$20.1M Buy
1,301,500
+101,500
+8% +$1.54M 0.3% 70
2014
Q4 		$19M Buy
1,200,000
+359,454
+43% +$4.68M 0.3% 70
2014
Q3 		$8.97M Buy
840,546
+210,166
+33% +$1.95M 0.15% 159
2014
Q2 		$5.92M Buy
+630,380
New +$4.03M 0.09% 203

Other funds holding TGTX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.6B AUM 47.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return